scholarly journals Change in Bone Mineral Density and Role of Vitamin D and Calcium Supplementation During Treatment of First Episode Nephrotic Syndrome

2017 ◽  
Author(s):  
Virendra Kumar Yadav
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Nephrotic Syndrome ◽  
Bone Mineral ◽  
Calcium Supplementation ◽  
First Episode ◽  
Mineral Density

scholarly journals Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements

2005 ◽  
Vol 20 (8) ◽  
pp. 1598-1603 ◽  
Author(s):  
Sanjeev Gulati ◽  
Raj K. Sharma ◽  
Kiran Gulati ◽  
Uttam Singh ◽  
Arvind Srivastava
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Nephrotic Syndrome ◽  
Bone Mineral ◽  
Mineral Density ◽  
Vitamin D Supplements

scholarly journals Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre‐exposure prophylaxis

2020 ◽  
Vol 23 (10) ◽  
Author(s):  
Krittaporn Pornpaisalsakul ◽  
Wipaporn Natalie Songtaweesin ◽  
Supatporn Tepmongkol ◽  
Prissana Wongharn ◽  
Surinda Kawichai ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Bone Mineral ◽  
Calcium Supplementation ◽  
Mineral Density ◽  
Exposure Prophylaxis

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D

2013 ◽  
Vol 24 (10) ◽  
pp. 2571-2579 ◽  
Author(s):  
S. M. H. Alibhai ◽  
H. Z. Mohamedali ◽  
H. Gulamhusein ◽  
A. H. Panju ◽  
H. Breunis ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Androgen Deprivation Therapy ◽  
Bone Mineral ◽  
Protective Role ◽  
Androgen Deprivation ◽  
Mineral Density

Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study

2019 ◽  
Vol 49 (4) ◽  
pp. 292-298
Author(s):  
Indar K Sharawat ◽  
Lesa Dawman ◽  
Merabhai V Kumkhaniya ◽  
Kusum Devpura ◽  
Amarjeet Mehta
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Nephrotic Syndrome ◽  
Bone Mineral ◽  
Idiopathic Nephrotic Syndrome ◽  
Serum Vitamin ◽  
Z Score ◽  
Mineral Density ◽  
Serum Vitamin D ◽  
Vitamin D Levels

Glucocorticoids are first-line therapy for children with idiopathic nephrotic syndrome (INS). These children are at risk of deranged bone metabolism and low bone mineral density (BMD). We studied 60 children with INS and divided them into two groups. Group 1 included 21 children (initial and infrequent relapsing) and group 2 included 39 children (frequent relapsing, steroid dependent and steroid resistant). Dual-energy X-ray absorptiometry of the lumbar spine was performed to assess BMD. Mean BMD Z-score was compared in both groups; this correlated significantly on univariate analysis with cumulative steroid dose, serum vitamin D levels and calcium supplementation. However, on multivariate analysis, serum vitamin D level was the only factor significantly predictive of low z-score.

scholarly journals Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome

Nephrology ◽  
2016 ◽  
Vol 21 (6) ◽  
pp. 483-489 ◽  
Author(s):  
Abhinav Aggarwal ◽  
Ashok K Yadav ◽  
Raja Ramachandran ◽  
Vinod Kumar ◽  
Vivek Kumar ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Nephrotic Syndrome ◽  
Bone Mineral ◽  
Mineral Metabolism ◽  
Mineral Density ◽  
Vitamin D Levels ◽  
Bioavailable Vitamin D

scholarly journals D-vitamin-anyagcsere és osteoporosis szisztémás sclerosisban

2017 ◽  
Vol 158 (32) ◽  
pp. 1252-1258 ◽  
Author(s):  
Szilvia Szamosi ◽  
Ágnes Horváth ◽  
Zoltán Szekanecz ◽  
Gabriella Szűcs
Keyword(s):  
Bone Mineral Density ◽  
Vitamin D ◽  
Systemic Sclerosis ◽  
Bone Density ◽  
Vitamin D Deficiency ◽  
Bone Mineral ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Low Bone Density

Abstract: In the past few years more and more data have become available on the important role of vitamin D in immunological processes and inflammation. The role of vitamin D deficiency in the pathogenesis as well as in disease progression of different autoimmune and inflammatory conditions is suspected. Vitamin D deficiency is prevalent in several autoimmune diseases, including systemic sclerosis. Hypovitaminosis has been found to be associated with low bone mineral density and higher prevalence of osteoporosis in this group of patients. Determinants of low bone density in SSc are poorly understood. Studies have shown the importance of both traditional osteoporotic as well as disease-specific factors (extent of skin involvement, presence of internal organ manifestation, malabsorption, systemic sclerosis subtype, serological profile, medication) in the development of low bone mineral density. The relationship between low bone density in systemic sclerosis patients and the above mentioned risk factors may be more complex and the real role of each factor is unclear. Yet very few studies reported clinically relevant low bone mass outcomes such as fracture risk assessment and fracture associated mortality in scleroderma. This review aims to synthesize data about the essential role of vitamin D in immune homeostasis as well as the prevalence of hypovitaminosis, low bone density, changes in bone turnover markers and presence of osteoporosis in scleroderma patients. Orv Hetil. 2017; 158(32): 1252–1258.

scholarly journals The effect of calcium and vitamin D on bone mineral density in patients taking glucocorticoid therapies: Protocol for a systematic review and network meta-analysis

2020 ◽  
Author(s):  
Jiawen Deng
Keyword(s):  
Bone Mineral Density ◽  
Systematic Review ◽  
Vitamin D ◽  
Bone Mineral ◽  
Inflammatory Diseases ◽  
Calcium Supplementation ◽  
Meta Analysis ◽  
Vitamin D Metabolites ◽  
Mineral Density ◽  
Autoimmune And Inflammatory Diseases

ABSTRACTGlucocorticoid (GC) administration is an effective therapy commonly used in the treatment of autoimmune and inflammatory diseases. However, the use of GC can give rise to serious complications. The main detrimental side effect of GC therapy is significant bone loss, resulting in glucocorticoid-induced osteoporosis (GIOP).We performed a systematic review and network meta-analysis (NMA) to evaluate whether the use of calcium supplementation, with or without vitamin D, vitamin D metabolites and vitamin D analogues is capable of increasing bone mineral density (BMD) at the lumbar spine, femoral neck, and hip in adult patients undergoing glucocorticoid therapies compared to no treatment.

Sign in / Sign up

Export Citation Format

Share Document